The Germany in vitro fertilization market size accounted for USD 1.75 billion in 2025 and is predicted to touch around USD 3.10 billion by 2035, growing at a CAGR of 5.9% from 2026 to 2035. The increasing number of infertility cases and advanced medical technologies are boosting the demand for in vitro fertilization.

Germany in Vitro Fertilization Market Statical Scope

In vitro fertilization (IVF) is a process that involves the artificial fertilization of extracted egg cells by sperm in a laboratory dish. The retrieved eggs are placed in a petri dish along with specially washed sperm. This process leads to fertilization and the formation of embryos, which are then transferred to a woman's uterus for implantation. IVF is used for patients with tubal infertility, idiopathic infertility, male fertility issues, and more.

IVF treatment is in high demand in Germany, with 1 in every 4 couples experiencing infertility. Through IVF, many couples fulfill their dreams of parenthood. The growth of the IVF market in Germany is driven by subsidized IVF treatments, delayed marriages and parenting decisions, and an increase in infertility cases.

Germany in Vitro Fertilization Market Share, By Instrument, (%)

• Disposable devices - High usage in IVF procedures due to single-use safety and contamination prevention, with a 58% share, establishes disposable devices as the leading instrument segment.
• Culture media - Demand for superior embryo development and increasing ART success rates are boosting the demand for culture media, with 32% share.
• Equipment - Includes incubators and imaging systems, with a 10% share, driven by advancements in reproductive technologies.

Germany in Vitro Fertilization Market Share, By Procedure Type, (%)

• Frozen donor- Higher success rates, better scheduling flexibility, and donor availability, with a 48% share, establish frozen donor as the leading procedure type.
• Fresh donor- Used in specific cases, with a 24% share, serves a crucial niche for patients with severe infertility.
• Fresh non- donor- Limited application, with a 15% share, preferred for initial IVF attempts.
• Frozen non-donor- Increasing adoption, with a 13% share, driven by increased flexibility in planning and higher success rates of frozen embryo transfers.

Germany in Vitro Fertilization Market Share, By Providers, (%)

• Fertility clinics - Specialised infrastructure and expertise in assisted reproductive technologies, with 80% share, establishes fertility clinics as the leading provider segment.
• Hospitals & other settings - Provides supportive services, with a 20% share, catering to patients requiring complex care or integrated services.

Top Companies in the Germany in Vitro Fertilization Market

• Bayer AG
• Cook Medical LLC
• VivaNeo
• Ferring B.V.
• Genea Biomedx
• EMD Serono, Inc. (Merck KGaA)
• Merck & Co., Inc.
• Thermo Fisher Scientific, Inc.
• Vitrolife

Segments Covered in the Report

By Instrument

• Disposable Devices
• Culture Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other

By Procedure

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

By Providers

• Fertility Clinics
• Hospitals & Other Setting